Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2018-01-20 00:10 CET (UTC+1h)
 

Crushed Rivaroxaban? [Regulatives / Guidelines]

posted by Averroes - Spain, 2018-01-09 12:00  - Posting: # 18152
Views: 113

» This point of the Q&A may be confusing and may clash to what is indicated in the product specific quidelines of some products. An example:
»
» -Ticagrelor: SmPC of Ticagrelor indicates that the tablets can be crushed to a fine powder mixed with 1/2 glass of water and administered. It also allows to administer via nasogastric tube. However the Product specific guideline here ask only for fasting study.

I just realized the same may apply to Rivaroxaban: According topoint 3.6 of EMA's Q&A regulators could ask for a BE study on crushed tablets while the Product Specific Guideline ask "only" for fast (10 mg) and fed (20 mg) studies.

Could we expect a new version of this Product Specific Guideline?

Thanks,

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,720 Posts in 3,785 Threads, 1,104 registered users;
27 users online (0 registered, 27 guests).

Mankind has survived all catastrophes.
It will also survive modern medicine.    Gerhard Kocher

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed